2008
DOI: 10.1097/pas.0b013e3181484f6d
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune Lymphoproliferative Syndrome (ALPS) Caused by Fas (CD95) Mutation Mimicking Sarcoidosis

Abstract: Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder associated with defects in apoptosis, characterized by childhood onset of lymphadenopathy, splenomegaly, hyperimmunoglobulinemia, and autoimmune disease. ALPS is most frequently associated with a mutation in the cell death receptor Fas (CD95). Very rarely a mutation in caspase 10 is present. An increase of CD4/CD8 double negative T cells in the peripheral blood and lymph nodes is a feature characteristic of ALPS. Additionally, histiocytic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…These results together with other evidence [26][27][28][29] suggest that the increased number of DN T cells may represent a sensitive test or biomarker to screen patients who should undergo testing for ALPS. In this regard it is interesting to mention that the analysis of DN T cell levels has been used to distinguish ALPS from other autoimmune disease such as Evans syndrome [27] or sarcoidosis [47]. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 10 amount of IL-17A during the early stages of infection (7 days) while CD4+ T cells start to produce this cytokine later (14 days) [48].…”
Section: Page 9 Of 29mentioning
confidence: 99%
“…These results together with other evidence [26][27][28][29] suggest that the increased number of DN T cells may represent a sensitive test or biomarker to screen patients who should undergo testing for ALPS. In this regard it is interesting to mention that the analysis of DN T cell levels has been used to distinguish ALPS from other autoimmune disease such as Evans syndrome [27] or sarcoidosis [47]. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 10 amount of IL-17A during the early stages of infection (7 days) while CD4+ T cells start to produce this cytokine later (14 days) [48].…”
Section: Page 9 Of 29mentioning
confidence: 99%
“…For example, in Systemic Lupus Erythematosus (SLE) patients, DN T cell numbers were found to be significantly increased and were a major producer of IL-17, the key inflammatory cytokine in SLE (2). Similarly, in Autoimmune Lymphoproliferative Syndrome (ALPS) patients, peripheral DN T cell numbers have been reported to increase from 1% in controls to 40% of T cells, making DN T cell number a potential disease biomarker (3). Peripheral DN T cell numbers have also been shown to increase in HIV patients.…”
mentioning
confidence: 99%
“…Benign histiocytic proliferations have been described previously by our group,13 as well others,15 in the context of ALPS, although these generally do not attain clinical significance. We previously characterized the occurrence of SHML-type S-100 positive histiocytes reminiscent of Rosai-Dorfman disease (RDD) in a cohort of 44 patients with ALPS Type Ia 13.…”
mentioning
confidence: 55%